Developing point-of-care technologies for early cancer detection
Official title: Technology Core
Funded at Rice University · NIH-10928780 · Data updated 2026-11-12
This study is working on creating easy-to-use and affordable cancer tests that can be done in local healthcare settings, especially for communities that need them the most, so everyone can get the early detection they deserve.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 13, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $703,352 |
| NIH project number | 5U54EB034652-02 |
| Project ID | NIH-10928780 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from underserved populations who may have limited access to traditional cancer screening methods.
✕Less likely to help
Patients who are already receiving regular and comprehensive cancer screening may not benefit directly from this research.
What this research studies
This research focuses on advancing point-of-care (POC) testing technologies specifically for cancer screening and early detection, particularly in underserved populations. It aims to identify and support innovative projects that can create high-performance, affordable tests that can be used in decentralized healthcare settings. By leveraging the successes of COVID-19 testing, the research seeks to overcome existing barriers to effective cancer detection and improve access to essential diagnostics. The approach involves collaboration with various stakeholders to ensure that these technologies are both effective and equitable.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and effective cancer screening methods, improving early detection rates and outcomes for patients.
How similar studies have gone: Previous research has shown success in developing point-of-care testing technologies for infectious diseases, suggesting a promising potential for similar advancements in cancer detection.
Where this research is happening
-
Rice University
Houston, United States Active
Researchers
- Principal investigator: Richards-Kortum, Rebecca R. — Rice University
- Study coordinator: Richards-Kortum, Rebecca R.
Related research
Other NIH-funded projects on the same topics.
-
Semi-autonomous surgeon-guided in situ robotic bioprinting for repairing volumetric muscle loss
A surgeon-guided robotic bioprinting system would print bioinks directly onto muscle injury sites to help restore function and appearance.
-
Center to Bring Quick Cancer Tests from Lab to Patients
A center is being built at Rice University to create and spread affordable, easy cancer tests that can be used in clinics and rural areas to catch cancer early.
-
Center for Innovation and Translation of Point-of-Care Cancer Tests to Reach More Patients
A center is being created to develop simple, low-cost point-of-care tests to detect cancers early, especially in low-resource settings, so more people can get timely care.
-
Point-of-care HPV DNA test to screen for cervical cancer in low-resource settings
A new HPV DNA test designed to be used at the point of care to screen for cervical cancer, especially in areas with limited medical infrastructure or rural settings.
-
Fast, easy HIV test that detects the virus early
This project is building a quick, instrument-free HIV-1 test that can detect the virus in blood or saliva earlier than current rapid tests for people at risk of recent exposure or possible viral rebound.
-
Deep profiling of how fusion-driven pediatric cancers spread, using single-cell protein tools
Researchers will develop fast, highly capable single-cell protein measurements to understand how certain pediatric cancers, like Ewing sarcoma, spread and evade the immune system.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.